STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and more
RegulatoryapprovedTrutaknaPositive
AI Analysis
Summary
The FDA approved Vera Therapeutics' Trutakna, a kidney disease drug indicated for IgA nephropathy treatment. This represents a significant regulatory milestone for the company.
Outcome Details
FDA approval for kidney disease drug Trutakna to treat IgA nephropathy
Importance:8/10
Sentiment:
0.90
FDA approvalkidney diseaseIgA nephropathyregulatory
Related Companies
Read the original article
Published by STAT News on July 8, 2026 1:11 PM